Prescription required
Insulin Degludec (2.56mg/1ml), Insulin Aspart (1.05mg/1ml)
Ryzodeg 100 Units per mL Penfill is a combination insulin containing insulin degludec and insulin aspart, providing both long acting basal coverage and rapid acting mealtime control. It is designed for adults with diabetes requiring improved glycemic stability. The dual component formulation helps manage fasting and post meal glucose levels effectively when used as directed.
Combination of ultra long and rapid acting insulin, Covers fasting and post meal glucose, Flexible dosing with main meal, Suitable for type 1 and type 2 diabetes, Stable glucose lowering profile
Insert penfill into compatible pen device, Attach new needle, Prime before injection, Inject subcutaneously with main meal as prescribed, Rotate injection sites, Dispose needle properly
Store in refrigerator at 2 to 8 degrees Celsius before use, Do not freeze, Keep away from heat and sunlight, Do not use if solution is abnormal, Regular glucose monitoring advised
Unsafe
Consult Your Doctor
Consult Your Doctor
Caution
Safe If Prescribed
Safe If Prescribed
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
In case of any issue, contact us
E-mail address: support@zeptonow.com
Geddit Convenience Private Limited
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
KA-B61-283317, KA-B61-283318
Novo Nordisk India Private Limited
Plot No.32, 47-50, EPIP Area, Whitefield, Bangalore - 560 066
DENMARK
30 months
September 2026